Pharmacokinetic/pharmacodynamic modeling of total lymphocytes and selected subtypes after oral budesonide. 2006

Jeffrey G Stark, and Sybille Werner, and Susanne Homrighausen, and Yufei Tang, and Michael Krieg, and Hartmut Derendorf, and Helmut Moellmann, and Guenther Hochhaus
Department of Pharmaceutics, College of Pharmacy, University of Florida, Gainesville, 32610, USA.

In the present pharmacokinetic/pharmacodynamic (PK/PD) evaluation, cortisol, total lymphocytes, and lymphocyte subpopulations were monitored following single oral doses of two oral formulations of 3 mg budesonide (BUD) (Dosage Forms A and B) in order to assess the differential effects that BUD may have on cortisol suppression and the modulation of blood lymphocyte subtypes. On a single occasion, five subjects received one 3 mg capsule of Dosage Form A, four received three capsules of Dosage Form A (single dose of 9 mg), and five received three capsules of Dosage Form B (single dose of 9 mg). Placebo capsules were administered to six subjects in the study. Cortisol concentrations, total lymphocyte counts, and lymphocyte subpopulation counts for the CD3, CD4, CD8, CD19, and CD56/16 were fitted to an in direct PK/PD response model that described the effects of BUD on serum cortisol concentrations as well as the combined effects of BUD and cortisol on total lymphocytes and the CD3, CD4, CD8, CD19, and CD56/16 subtypes. Data were also analyzed using noncompartmental methods. The PK/PD model fitted the data with the exception of data for CD56/16. The IC(50) value for unbound BUD acting on total lymphocytes was 0.276 ng/ml while the IC(50) values for unbound BUD acting on lymphocyte subtypes ranged from 0.150 ng/ml for CD4 to 0.364 ng/ml for CD8. The IC(50) values for the effects of BUD on serum cortisol were lower (0.079 ng/ml). The results of PK/PD modeling and noncompartmental analysis indicate that BUD has a smaller effect on the CD8 subtype and larger effects on the CD4 and CD19 subtypes, relative to the effect on total lymphocytes, and that cortisol suppression, although not a direct immunological biomarker, may be a more sensitive marker for the systemic effect of corticosteroids.

UI MeSH Term Description Entries
D007694 Killer Cells, Natural Bone marrow-derived lymphocytes that possess cytotoxic properties, classically directed against transformed and virus-infected cells. Unlike T CELLS; and B CELLS; NK CELLS are not antigen specific. The cytotoxicity of natural killer cells is determined by the collective signaling of an array of inhibitory and stimulatory CELL SURFACE RECEPTORS. A subset of T-LYMPHOCYTES referred to as NATURAL KILLER T CELLS shares some of the properties of this cell type. NK Cells,Natural Killer Cells,Cell, NK,Cell, Natural Killer,Cells, NK,Cells, Natural Killer,Killer Cell, Natural,NK Cell,Natural Killer Cell
D008214 Lymphocytes White blood cells formed in the body's lymphoid tissue. The nucleus is round or ovoid with coarse, irregularly clumped chromatin while the cytoplasm is typically pale blue with azurophilic (if any) granules. Most lymphocytes can be classified as either T or B (with subpopulations of each), or NATURAL KILLER CELLS. Lymphoid Cells,Cell, Lymphoid,Cells, Lymphoid,Lymphocyte,Lymphoid Cell
D008297 Male Males
D008954 Models, Biological Theoretical representations that simulate the behavior or activity of biological processes or diseases. For disease models in living animals, DISEASE MODELS, ANIMAL is available. Biological models include the use of mathematical equations, computers, and other electronic equipment. Biological Model,Biological Models,Model, Biological,Models, Biologic,Biologic Model,Biologic Models,Model, Biologic
D011485 Protein Binding The process in which substances, either endogenous or exogenous, bind to proteins, peptides, enzymes, protein precursors, or allied compounds. Specific protein-binding measures are often used as assays in diagnostic assessments. Plasma Protein Binding Capacity,Binding, Protein
D001798 Blood Proteins Proteins that are present in blood serum, including SERUM ALBUMIN; BLOOD COAGULATION FACTORS; and many other types of proteins. Blood Protein,Plasma Protein,Plasma Proteins,Serum Protein,Serum Proteins,Protein, Blood,Protein, Plasma,Protein, Serum,Proteins, Blood,Proteins, Plasma,Proteins, Serum
D002214 Capsules Hard or soft soluble containers used for the oral administration of medicine. Capsule,Microcapsule,Microcapsules
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D005434 Flow Cytometry Technique using an instrument system for making, processing, and displaying one or more measurements on individual cells obtained from a cell suspension. Cells are usually stained with one or more fluorescent dyes specific to cell components of interest, e.g., DNA, and fluorescence of each cell is measured as it rapidly transverses the excitation beam (laser or mercury arc lamp). Fluorescence provides a quantitative measure of various biochemical and biophysical properties of the cell, as well as a basis for cell sorting. Other measurable optical parameters include light absorption and light scattering, the latter being applicable to the measurement of cell size, shape, density, granularity, and stain uptake. Cytofluorometry, Flow,Cytometry, Flow,Flow Microfluorimetry,Fluorescence-Activated Cell Sorting,Microfluorometry, Flow,Cell Sorting, Fluorescence-Activated,Cell Sortings, Fluorescence-Activated,Cytofluorometries, Flow,Cytometries, Flow,Flow Cytofluorometries,Flow Cytofluorometry,Flow Cytometries,Flow Microfluorometries,Flow Microfluorometry,Fluorescence Activated Cell Sorting,Fluorescence-Activated Cell Sortings,Microfluorimetry, Flow,Microfluorometries, Flow,Sorting, Fluorescence-Activated Cell,Sortings, Fluorescence-Activated Cell
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

Jeffrey G Stark, and Sybille Werner, and Susanne Homrighausen, and Yufei Tang, and Michael Krieg, and Hartmut Derendorf, and Helmut Moellmann, and Guenther Hochhaus
April 1996, Journal of clinical pharmacology,
Jeffrey G Stark, and Sybille Werner, and Susanne Homrighausen, and Yufei Tang, and Michael Krieg, and Hartmut Derendorf, and Helmut Moellmann, and Guenther Hochhaus
June 2007, Pharmaceutical research,
Jeffrey G Stark, and Sybille Werner, and Susanne Homrighausen, and Yufei Tang, and Michael Krieg, and Hartmut Derendorf, and Helmut Moellmann, and Guenther Hochhaus
January 2000, Archives of medical research,
Jeffrey G Stark, and Sybille Werner, and Susanne Homrighausen, and Yufei Tang, and Michael Krieg, and Hartmut Derendorf, and Helmut Moellmann, and Guenther Hochhaus
June 1981, Journal of pharmacokinetics and biopharmaceutics,
Jeffrey G Stark, and Sybille Werner, and Susanne Homrighausen, and Yufei Tang, and Michael Krieg, and Hartmut Derendorf, and Helmut Moellmann, and Guenther Hochhaus
January 1997, Proceedings of the Western Pharmacology Society,
Jeffrey G Stark, and Sybille Werner, and Susanne Homrighausen, and Yufei Tang, and Michael Krieg, and Hartmut Derendorf, and Helmut Moellmann, and Guenther Hochhaus
September 2021, Thyroid : official journal of the American Thyroid Association,
Jeffrey G Stark, and Sybille Werner, and Susanne Homrighausen, and Yufei Tang, and Michael Krieg, and Hartmut Derendorf, and Helmut Moellmann, and Guenther Hochhaus
January 1996, Methods and findings in experimental and clinical pharmacology,
Jeffrey G Stark, and Sybille Werner, and Susanne Homrighausen, and Yufei Tang, and Michael Krieg, and Hartmut Derendorf, and Helmut Moellmann, and Guenther Hochhaus
May 2005, Journal of pain and symptom management,
Jeffrey G Stark, and Sybille Werner, and Susanne Homrighausen, and Yufei Tang, and Michael Krieg, and Hartmut Derendorf, and Helmut Moellmann, and Guenther Hochhaus
August 2016, Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference,
Jeffrey G Stark, and Sybille Werner, and Susanne Homrighausen, and Yufei Tang, and Michael Krieg, and Hartmut Derendorf, and Helmut Moellmann, and Guenther Hochhaus
January 1981, Critical reviews in bioengineering,
Copied contents to your clipboard!